These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Transarterial chemoembolization and yittrium-90 for liver cancer and other lesions. Minocha J, Salem R, Lewandowski RJ. Clin Liver Dis; 2014 Nov; 18(4):877-90. PubMed ID: 25438288 [Abstract] [Full Text] [Related]
4. Pretransplant Intra-arterial Liver-Directed Therapy Does Not Increase the Risk of Hepatic Arterial Complications in Liver Transplantation: A Single-Center 10-Year Experience. Kallini JR, Gabr A, Ali R, Abouchaleh N, Riaz A, Baker T, Kulik L, Caicedo J, Salem R, Lewandowski RJ. Cardiovasc Intervent Radiol; 2018 Feb; 41(2):231-238. PubMed ID: 28900709 [Abstract] [Full Text] [Related]
7. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma. Golfieri R, Bilbao JI, Carpanese L, Cianni R, Gasparini D, Ezziddin S, Paprottka PM, Fiore F, Cappelli A, Rodriguez M, Ettorre GM, Saltarelli A, Geatti O, Ahmadzadehfar H, Haug AR, Izzo F, Giampalma E, Sangro B, Pizzi G, Notarianni E, Vit A, Wilhelm K, Jakobs TF, Lastoria S, European Network on Radioembolization with Yttrium-90 Microspheres (ENRY) study collaborators. J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371 [Abstract] [Full Text] [Related]
8. Current role of portal vein embolization/hepatic artery chemoembolization. Kokudo N, Makuuchi M. Surg Clin North Am; 2004 Apr; 84(2):643-57. PubMed ID: 15062666 [Abstract] [Full Text] [Related]
9. Role of interventional radiology in the treatment of patients with neuroendocrine metastases in the liver. Kvols LK, Turaga KK, Strosberg J, Choi J. J Natl Compr Canc Netw; 2009 Jul; 7(7):765-72. PubMed ID: 19635229 [Abstract] [Full Text] [Related]
10. Role of yttrium-90 in the management of unresectable hepatocellular carcinoma and hepatic metastases. Kousik V, Promila P, Verma R, Gupta A. Indian J Gastroenterol; 2016 May; 35(3):179-85. PubMed ID: 27185180 [Abstract] [Full Text] [Related]
11. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion. Spreafico C, Sposito C, Vaiani M, Cascella T, Bhoori S, Morosi C, Lanocita R, Romito R, Chiesa C, Maccauro M, Marchianò A, Mazzaferro V. J Hepatol; 2018 Apr; 68(4):724-732. PubMed ID: 29331342 [Abstract] [Full Text] [Related]
12. Management of large hepatocellular carcinoma by sequential transarterial chemoembolization and portal vein embolization: a systematic review of the literature. Piardi T, Memeo R, Renard Y, Ammendola M, Bruno O, Habersetzer F, Baumert T, Pessaux P, Sommacale D. Minerva Chir; 2016 Jun; 71(3):192-200. PubMed ID: 26883849 [Abstract] [Full Text] [Related]
14. Hepatectomy After Yttrium-90 (Y90) Radioembolization-Induced Liver Fibrosis. Maker AV, August C, Maker VK, Weisenberg E. J Gastrointest Surg; 2016 Apr; 20(4):869-70. PubMed ID: 26847353 [Abstract] [Full Text] [Related]
15. Radioembolization for the treatment of hepatocellular carcinoma. Kim HC. Clin Mol Hepatol; 2017 Jun; 23(2):109-114. PubMed ID: 28494530 [Abstract] [Full Text] [Related]
16. Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality. Kim DY, Han KH. Hepatol Int; 2016 Nov; 10(6):883-892. PubMed ID: 27126821 [Abstract] [Full Text] [Related]
17. Y90 Radioembolization Dosimetry: Concepts for the Interventional Radiologist. Toskich BB, Liu DM. Tech Vasc Interv Radiol; 2019 Jun; 22(2):100-111. PubMed ID: 31079706 [Abstract] [Full Text] [Related]
18. Balloon-assisted radioembolization via the proper hepatic artery to treat a left liver hepatocellular carcinoma and portal vein tumor thrombus with an inaccessible left hepatic artery: A case report. Mabey JG, Cornman-Homonoff J, Madoff DC. Clin Imaging; 2022 Feb; 82():244-250. PubMed ID: 34920388 [Abstract] [Full Text] [Related]
19. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study. Kwon JH, Kim GM, Han K, Won JY, Kim MD, Lee DY, Lee J, Choi W, Kim YS, Kim DY, Han KH. Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511 [Abstract] [Full Text] [Related]
20. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease. Fidelman N, Kerlan RK. AJR Am J Roentgenol; 2015 Oct; 205(4):742-52. PubMed ID: 26397322 [Abstract] [Full Text] [Related] Page: [Next] [New Search]